Evidence map›Paper›PMID 36904871›Full record

ArticleSensors (Basel, Switzerland)2023

Discrimination of Deoxynivalenol Levels of Barley Kernels Using Hyperspectral Imaging in Tandem with Optimized Convolutional Neural Network.

Ke-Jun Fan, Bo-Yuan Liu, Wen-Hao Su

Full text read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ke-Jun FanCollege of Engineering, China Agricultural University, Beijing 100083, China.
Bo-Yuan LiuCollege of Engineering, China Agricultural University, Beijing 100083, China.
Wen-Hao SuCollege of Engineering, China Agricultural University, Beijing 100083, China.ORCID 0000-0003-1745-4722

Funding

National Natural Science Foundation of China 32101610
6 · The paper itself

Abstract

Deoxynivalenol (DON) in raw and processed grain poses significant risks to human and animal health. In this study, the feasibility of classifying DON levels in different genetic lines of barley kernels was evaluated using hyperspectral imaging (HSI) (382-1030 nm) in tandem with an optimized convolutional neural network (CNN). Machine learning methods including logistic regression, support vector machine, stochastic gradient descent, K nearest neighbors, random forest, and CNN were respectively used to develop the classification models. Spectral preprocessing methods including wavelet transform and max-min normalization helped to enhance the performance of different models. A simplified CNN model showed better performance than other machine learning models. Competitive adaptive reweighted sampling (CARS) in combination with successive projections algorithm (SPA) was applied to select the best set of characteristic wavelengths. Based on seven wavelengths selected, the optimized CARS-SPA-CNN model distinguished barley grains with low levels of DON (<5 mg/kg) from those with higher levels (5 mg/kg < DON ≤ 14 mg/kg) with an accuracy of 89.41%. The lower levels of DON class I (0.19 mg/kg ≤ DON ≤ 1.25 mg/kg) and class II (1.25 mg/kg < DON ≤ 5 mg/kg) were successfully distinguished based on the optimized CNN model, yielding a precision of 89.81%. The results suggest that HSI in tandem with CNN has great potential for discrimination of DON levels of barley kernels.

Indexed as

HordeumAlgorithmsHumansHyperspectral ImagingNeural Networks, ComputerSupport Vector MachineTrichothecenesdeoxynivalenolTrichothecenesconvolutional neural networkdeoxynivalenolfeature wavelength selectionhyperspectral imaging

Identifiers

PMID36904871
PMCPMC10007200

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read72
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.